IDXX Q3 2020 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$722M+19.2% YoY

Gross Profit

$423M58.5% margin

Operating Income

$172M23.8% margin

Net Income

$146M20.3% margin

EPS (Diluted)

$1.69

QoQ Revenue Growth

+13.2%

Cash Flow

Operating Cash Flow

$193M

Free Cash Flow

$174M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.6B

Stockholders' Equity

$441M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$722M	$605M	+19.2%
Gross Profit	$423M	$345M	+22.5%
Operating Income	$172M	$140M	+22.9%
Net Income	$146M	$109M	+34.3%

Revenue Segments

Up Front Customer Loyalty Programs And Volume Commitment Programs

$2.0B98%

Reagent Rental Programs

$26M1%

Extended Warranties And Post Contract Support

$21M1%

Instrument Rebate Programs

$4M0%

Geographic Segments

UNITED STATES

$455M63%

EMEA

$147M20%

Asia Pacific

$77M11%

CANADA

$29M4%

Latin America

$14M2%